Formulation and in-vitro bioequivalence evaluation of verapamil hydrochloride matrix tablets with Calan SR.

Bashir, Irfan; Sethi, Ayesha; Zaman, Muhammad; Qureshi, Junaid; Sarfraz, Rai M; Mahmood, Asif; Sajid, Muhammad I; Jamshaid, Talha; Akram, Muhammad A.
Artículo en Inglés | IMSEAR | ID: sea-153098

Documentos relacionados

  1. Formulation and in-vitro bioequivalence evaluation of verapamil hydrochloride matrix tablets with Calan R.
  2. Exploring the potential of natural polymers from plants as tablet binder and accessing their release profiles: A comparative analysis.
  3. In vitro comparative quality evaluation of different brands of carbamazepine tablets commercially available in Dessie town, Northeast Ethiopia.
  4. Prediction of plasma concentrations using in silico modelling and simulation approach: Case of Acebutolol.
  5. Development, validation and application of physiologically based biopharmaceutics model to justify the change in dissolution specifications for DRL ABC extended release tablets.
  6. Efficient drug development of oseltamivir capsules based on process control, bioequivalence and PBPK modeling.
  7. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen.
  8. Bioequivalence Dissolution Test Criteria for Formulation Development of High Solubility-Low Permeability Drugs.
  9. Novel bioequivalent oral disintegrating tablet of aripiprazole prepared by direct compression technique with shortened disintegration time.
  10. In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil.